its derivatives (2) with halogen substituents on the fused benzene ring were synthesized. These compounds were evaluated for their effects on vertebral and coronary blood flows and antihypertensive activity. The structure-activity relationships are discussed. The 8-chloro derivative ((+)-2b), the most potent compound in this series, was selected for clinical evaluation as a cerebral vasodilating and
Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17β-hydroxysteroid dehydrogenase type 3
作者:Brian E. Fink、Ashvinikumar V. Gavai、John S. Tokarski、Bindu Goyal、Raj Misra、Hai-Yun Xiao、S. David Kimball、Wen-Ching Han、Derek Norris、Thomas E. Spires、Dan You、Marco M. Gottardis、Matthew V. Lorenzi、Gregory D. Vite
DOI:10.1016/j.bmcl.2005.12.039
日期:2006.3
A novel series of 17 beta-hydroxysteroid dehydrogenase type 3 (17 beta-HSD3) inhibitors has been identified. These inhibitors, based on a dibenzazocine core, exhibited picomolar to low nanomolar inhibition of 17 beta-HSD3 in cell-free enzymatic as well as in cell-based transcriptional reporter assays. (C) 2005 Elsevier Ltd. All rights reserved.